{"symbol":"SZ300760","secucode":"300760.SZ","items":[{"title":"深圳市委书记靳磊到大疆、迈瑞、优必选等企业调研","summary":"据深圳特区报消息，近日，深圳市委书记靳磊先后到大疆创新科技有限公司、深圳迈瑞生物医疗电子股份有限公司、深圳市优必选科技股份有限公司调研，与企业负责人深入交流，详细了解企业生产经营和创新发展情况，并就进一步做好服务保障，优化创新环境和产业生态等听取意见建议。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606073762632862.html","info_code":"NW202606073762632862","show_time_timestamp":1780791379000,"show_time":"2026-06-07 08:16:19","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606073762632862.html","url":"http://finance.eastmoney.com/news/1354,202606073762632862.html","code":"202606073762632862","infoCode":"NW202606073762632862","recordId":null,"source":null,"title":"深圳市委书记靳磊到大疆、迈瑞、优必选等企业调研","updateTime":0,"showDateTime":1780791379000,"publishDate":0,"sRatingName":null,"summary":"据深圳特区报消息，近日，深圳市委书记靳磊先后到大疆创新科技有限公司、深圳迈瑞生物医疗电子股份有限公司、深圳市优必选科技股份有限公司调研，与企业负责人深入交流，详细了解企业生产经营和创新发展情况，并就进一步做好服务保障，优化创新环境和产业生态等听取意见建议。"}},{"title":"“六张网”织就新底座 数智赋能医药高质量发展","summary":"“全国一体化算力网建设，将为医药人工智能应用提供更加集约、弹性、稳定的基础支撑。医药研发具有数据量大、专业链条长、模型验证要求高、合规约束强等特点，药物发现、结构优化、药理毒理预测、临床研究、医学写作、药物警戒、项目评估等场景，均需要持续、可靠、可调度的算力资源保障。”复星医药负责人表示。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606063762341595.html","info_code":"NW202606063762341595","show_time_timestamp":1780701027000,"show_time":"2026-06-06 07:10:27","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606063762341595.html","url":"http://finance.eastmoney.com/news/1354,202606063762341595.html","code":"202606063762341595","infoCode":"NW202606063762341595","recordId":null,"source":null,"title":"“六张网”织就新底座 数智赋能医药高质量发展","updateTime":0,"showDateTime":1780701027000,"publishDate":0,"sRatingName":null,"summary":"“全国一体化算力网建设，将为医药人工智能应用提供更加集约、弹性、稳定的基础支撑。医药研发具有数据量大、专业链条长、模型验证要求高、合规约束强等特点，药物发现、结构优化、药理毒理预测、临床研究、医学写作、药物警戒、项目评估等场景，均需要持续、可靠、可调度的算力资源保障。”复星医药负责人表示。"}},{"title":"迈瑞医疗：深圳迈瑞软件技术有限公司主要从事软件产品的开发和销售","summary":"证券日报网讯6月5日，迈瑞医疗在互动平台回答投资者提问时表示，深圳迈瑞软件技术有限公司主要从事软件产品的开发和销售，销售收入和利润均来自于软件产品的销售。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606053762246619.html","info_code":"NW202606053762246619","show_time_timestamp":1780664760000,"show_time":"2026-06-05 21:06:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606053762246619.html","url":"http://finance.eastmoney.com/news/1354,202606053762246619.html","code":"202606053762246619","infoCode":"NW202606053762246619","recordId":null,"source":null,"title":"迈瑞医疗：深圳迈瑞软件技术有限公司主要从事软件产品的开发和销售","updateTime":0,"showDateTime":1780664760000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯6月5日，迈瑞医疗在互动平台回答投资者提问时表示，深圳迈瑞软件技术有限公司主要从事软件产品的开发和销售，销售收入和利润均来自于软件产品的销售。"}},{"title":"迈瑞医疗：公司生产经营一切正常","summary":"证券日报网讯6月5日，迈瑞医疗在互动平台回答投资者提问时表示，股价波动受到公司业绩、宏观经济、行业政策、市场情绪等诸多因素影响，非单一因素决定。公司生产经营一切正常。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606053762198653.html","info_code":"NW202606053762198653","show_time_timestamp":1780663200000,"show_time":"2026-06-05 20:40:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606053762198653.html","url":"http://finance.eastmoney.com/news/1354,202606053762198653.html","code":"202606053762198653","infoCode":"NW202606053762198653","recordId":null,"source":null,"title":"迈瑞医疗：公司生产经营一切正常","updateTime":0,"showDateTime":1780663200000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯6月5日，迈瑞医疗在互动平台回答投资者提问时表示，股价波动受到公司业绩、宏观经济、行业政策、市场情绪等诸多因素影响，非单一因素决定。公司生产经营一切正常。"}},{"title":"业绩大面积下滑，股权转让频发！IVD 行业上演“大鱼吃小鱼”，已步入深度整合期？","summary":"5月以来，IVD（体外诊断）上市企业股权转让事件频繁。4日晚，艾德生物（300685.SZ）发布公告称，公司控股股东前瞻投资（香港）有限公司及公司实际控制人、董事长郑立谋于近日与国药集团（北京）科技创新研究院有限公司签署了《股份收购协议》。国药集团（北京）科技创新研究院有限公司将成为公司控股股东，公司实际控制人将变更为中国医药集团有限公司。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606053762043375.html","info_code":"NW202606053762043375","show_time_timestamp":1780651262000,"show_time":"2026-06-05 17:21:02","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606053762043375.html","url":"http://finance.eastmoney.com/news/1354,202606053762043375.html","code":"202606053762043375","infoCode":"NW202606053762043375","recordId":null,"source":null,"title":"业绩大面积下滑，股权转让频发！IVD 行业上演“大鱼吃小鱼”，已步入深度整合期？","updateTime":0,"showDateTime":1780651262000,"publishDate":0,"sRatingName":null,"summary":"5月以来，IVD（体外诊断）上市企业股权转让事件频繁。4日晚，艾德生物（300685.SZ）发布公告称，公司控股股东前瞻投资（香港）有限公司及公司实际控制人、董事长郑立谋于近日与国药集团（北京）科技创新研究院有限公司签署了《股份收购协议》。国药集团（北京）科技创新研究院有限公司将成为公司控股股东，公司实际控制人将变更为中国医药集团有限公司。"}}]}